Literature DB >> 1643018

Chromosome 11q rearrangements in B non Hodgkin's lymphoma.

E Vandenberghe1, C De Wolf Peeters, I Wlodarska, M Stul, A Louwagie, G Verhoef, J Thomas, A Criel, J J Cassiman, C Mecucci.   

Abstract

The clinical features, morphology and immunophenotype of 20 cases of B non Hodgkin's lymphoma (B-NHL) with chromosome abnormalities involving 11q13-14 were studied, to determine if this abnormality was closely associated with a specific sub-type of B-NHL. A t(11;14)(q13;q32) was found in 11 cases of intermediately differentiated lymphocytic lymphoma (IDLL). A breakpoint in the major translocation cluster of the BCL-1 locus was found in six of these cases. These patients were male with lymphomatous involvement of the bone marrow, marked splenomegaly and frequently had mucosa associated lymphoid tissue involvement. One patient with IDLL had a t(8;11)(p21;q13) and a rearranged BCL-1 locus, suggesting that this may be a variant of t(11;14)(q13;q32). Diagnoses of IDLL, chronic lymphocytic leukaemia, lymphoplasmacytic lymphoma and monocytoid B cell lymphoma were made in all but one of the remaining cases. These cases had either a translocation involving 11q13-14 and various partner chromosomes or an 11q13 deletion. This study demonstrates that 11q abnormalities occur mainly in a group of low-grade B-NHL of non follicle centre cell lineage.

Entities:  

Mesh:

Year:  1992        PMID: 1643018     DOI: 10.1111/j.1365-2141.1992.tb08209.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization.

Authors:  J Y Li; F Gaillard; A Moreau; J L Harousseau; C Laboisse; N Milpied; R Bataille; H Avet-Loiseau
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Mantle cell lymphoma is characterized by inactivation of the ATM gene.

Authors:  C Schaffner; I Idler; S Stilgenbauer; H Döhner; P Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

4.  Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.

Authors:  W I Yang; L R Zukerberg; T Motokura; A Arnold; N L Harris
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 5.  Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.

Authors:  Marta Migocka-Patrzałek; Magdalena Elias
Journal:  Cells       Date:  2021-04-13       Impact factor: 6.600

6.  Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.

Authors:  Francis R LeBlanc; Zainul S Hasanali; August Stuart; Sara Shimko; Kamal Sharma; Violetta V Leshchenko; Samir Parekh; Haiqing Fu; Ya Zhang; Melvenia M Martin; Mark Kester; Todd Fox; Jiangang Liao; Thomas P Loughran; Juanita Evans; Jeffrey J Pu; Stephen E Spurgeon; Mirit I Aladjem; Elliot M Epner
Journal:  Oncotarget       Date:  2022-08-16

7.  BCL-1 Gene Rearrangements in Iranian Non-Hodgkin Lymphoma Patients.

Authors:  Manoush Tohidirad; Mehrdad Asghari Estiar; Azim Rezamand; Saeid Ghorbian; Sasan Andalib; Issa Jahanzad; Tayyeb Bahrami; Ebrahim Sakhinia
Journal:  Glob J Health Sci       Date:  2016-08-01

8.  Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia.

Authors:  Amol Padgaonkar; Olga Rechkoblit; Rodgrigo Vasquez-Del Carpio; Venkat Pallela; Drc Venkata Subbaiah; Stephen C Cosenza; Stacey J Baker; M V Ramana Reddy; Aneel Aggarwal; E Premkumar Reddy
Journal:  Oncotarget       Date:  2018-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.